MA-CHAOSSEARCH
27.11.2023 15:06:32 CET | Business Wire | Press release
Today, ChaosSearch, a leader in data analytics, announced the integration of Chaos LakeDB with Amazon Bedrock from Amazon Web Services (AWS), a fully managed service that makes foundation models (FMs) from leading AI companies accessible via an API to build and scale generative AI applications. This integration is designed to transform the way organizations leverage generative artificial intelligence (AI) to interact with their unified data lakes for observability, security lakes, and application insight use cases, providing clients with enhanced simplicity, choice, and security. Chaos LakeDB customers can select any large language model (LLM) from Amazon Bedrock’s choice of high-performing FMs.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231127237186/en/
The combination of generative AI and ChaosSearch’s unified data lake offers new possibilities for enterprises. Chaos LakeDB opens these opportunities while delivering cost-effective scaling and simplifying working with data pipelines, data preparation, and data islands. It integrates with and orchestrates pre-trained generative AI models as a complement to Search and SQL analytics, creating an ideal launch point for enterprises to immediately realize efficiency improvements across observability, security lake, and application insight use cases.
"As a long-term partner with ChaosSearch, we've witnessed firsthand the transformative impact of their technology on our data analytics capabilities," said Jimmy McDermott of PATHWAYos. "The integration of Chaos LakeDB with Amazon Bedrock represents a leap forward in our ability to harness the full power of generative AI within our data strategy. The seamless and secure interaction with LLMs has allowed us to tap into a new dimension of data intelligence, optimizing our workflows, and enhancing our decision-making process. ChaosSearch's vision for the future of data interaction is not just a promise; it's a reality that's delivering exceptional value to our organization."
Chaos LakeDB integration with Amazon Bedrock allows users to engage with their data through a conversational AI interface, leveraging public and private LLM models. By utilizing prompt engineering and orchestrating chain-of-thought interaction, users can converse directly with their data with enhanced security. The integration leverages AWS’s data security and privacy best practices and no confidential or proprietary data is shared with the LLM. Furthermore, this design removes the challenges of complex and costly model training while preventing data hallucinations.
With the integration of Chaos LakeDB with Amazon Bedrock, organizations can further isolate their data in a private workspace where all exchanges of information between the database and the LLM are private. None of the customer’s data is used to train or fine-tune the underlying LLM. In essence, the LLM is private to the user account.
Chaos LakeDB’s integration with Amazon Bedrock delivers:
- Intuitive Data Exploration: Understand complex data effortlessly with ChaosSearch AI Assistant's ability to suggest, process queries, and surface crucial insights, eliminating the barrier of advanced analytical skills.
- Code Co-pilot: Receive smart support for writing and refining Elastic and SQL queries, with the assurance of secure processing.
- Enhanced Team Collaboration: Promote efficient teamwork and shared understanding through user-friendly data sharing and exploration tools, suitable for various expertise levels.
- Immediate Insights: Obtain real-time visibility into key operational areas such as system behavior, security monitoring, and application performance.
"AI is transforming business intelligence," said Dr. Sherry Marcus, director of Applied Science of Amazon Bedrock and Amazon Titan at Amazon Web Services. "The Chaos LakeDB integration with Amazon Bedrock is simplifying how customers engage with and analyze their data—and with the security and scalability that enterprises demand. Using conversational queries to interact with their data, customers will be able to glean deeper insights and make more informed decisions. We look forward to seeing how the power of generative AI will enhance customers’ business strategies."
"At ChaosSearch, we are deeply passionate about empowering our clients to conquer the ever-growing mountain of data analytics challenges," said Thomas Hazel, founder and CTO of ChaosSearch. "The integration of Chaos LakeDB with Amazon Bedrock is a critical milestone on our ambitious roadmap. It's designed to provide a straightforward, high-impact entry point for organizations embarking on their generative AI journey. We're not just enhancing our platform; we're providing a key that unlocks high-value insights while simplifying the journey to scale analytics. Our dedication to innovation is relentless, and this integration exemplifies our commitment to delivering not just solutions but pathways to transformation and growth that redefine analytics at scale for our clients."
An innovative solution for data interaction and analysis, Chaos LakeDB's integration with Amazon Bedrock is a powerful tool for businesses worldwide. As the company moves forward with its dynamic roadmap, clients can anticipate even more advanced features and capabilities tailored to their specific needs. As clients look to train their own models or augment existing FMs, Chaos LakeDB will play a critical role for creation, test data access and exporting for training and deploying generative AI models in production at scale without breaking the bank.
Chaos LakeDB and the integration with Amazon Bedrock is available in early access. Contact us, for more information or to request a demo.
About ChaosSearch:
ChaosSearch is redefining the boundaries of data analytics by offering transformative solutions that empower businesses to make data-driven decisions with unparalleled efficiency. Our ethos is centered on simplifying complexity and turning challenges into opportunities. Chaos LakeDB is at the forefront of revolutionizing data lake architectures in the AI-driven era. By seamlessly transforming cloud storage into a dynamic analytical database, it integrates diverse data streams, streamlines intricate pipelines, and delivers at scale actionable insights through Search+SQL+GenAI analytics. By eliminating manual redundancies and activating static data lakes, Chaos LakeDB provides businesses with both real-time and historical intelligence. As champions of innovation, ChaosSearch is dedicated to delivering tools that not only meet but also anticipate the evolving needs of modern businesses. Dive into a world where data is not just stored but becomes a dynamic force driving growth and innovation.
Leading cloud-based organizations, including Equifax, Cisco, Revinate, and Digital River, trust the ChaosSearch Cloud Data Platform. For more information, visit ChaosSearch.io or follow us on LinkedIn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231127237186/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
